Inclusion is particularly important for patients from populations where APOL1 risk alleles are enriched (e.g. West-African ancestry), especially when presenting with clinical features such as proteinuria or focal segmental glomerulosclerosis (FSGS) on biopsy [36]. Here, APOL1 is linked to focal segmental glomerulosclerosis.